Table 2.

Adverse and severe adverse events of OA patients after Re-Join® and HA treatment (n = 52)

Group	Number of patients	Number of injections	AEs, n	SAEs, n	Frequency of AE (%)	Frequency of SAEs (%)	P value
HA	26	104	14	1	53.85	3.846	0.1144
Re-Join@	26	103	19	0	73.07	0
Total	52	207	33	1	63.46	1.92

AE adverse event, SAE serious adverse events